» Articles » PMID: 9920888

Identification of a Domain of Axin That Binds to the Serine/threonine Protein Phosphatase 2A and a Self-binding Domain

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1999 Jan 28
PMID 9920888
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Axin is a negative regulator of embryonic axis formation in vertebrates, which acts through a Wnt signal transduction pathway involving the serine/threonine kinase GSK-3 and beta-catenin. Axin has been shown to have distinct binding sites for GSK-3 and beta-catenin and to promote the phosphorylation of beta-catenin and its consequent degradation. This provides an explanation for the ability of Axin to inhibit signaling through beta-catenin. In addition, a more N-terminal region of Axin binds to adenomatous polyposis coli (APC), a tumor suppressor protein that also regulates levels of beta-catenin. Here, we report the results of a yeast two-hybrid screen for proteins that interact with the C-terminal third of Axin, a region in which no binding sites for other proteins have previously been identified. We found that Axin can bind to the catalytic subunit of the serine/threonine protein phosphatase 2A through a domain between amino acids 632 and 836. This interaction was confirmed by in vitro binding studies as well as by co-immunoprecipitation of epitope-tagged proteins expressed in cultured cells. Our results suggest that protein phosphatase 2A might interact with the Axin.APC.GSK-3.beta-catenin complex, where it could modulate the effect of GSK-3 on beta-catenin or other proteins in the complex. We also identified a region of Axin that may allow it to form dimers or multimers. Through two-hybrid and co-immunoprecipitation studies, we demonstrated that the C-terminal 100 amino acids of Axin could bind to the same region as other Axin molecules.

Citing Articles

TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond.

Wu Q, Nandi D, Sharma D Cancer Metastasis Rev. 2024; 44(1):16.

PMID: 39644332 PMC: 11625080. DOI: 10.1007/s10555-024-10226-2.


Wnt/β-catenin signaling pathway: proteins' roles in osteoporosis and cancer diseases and the regulatory effects of natural compounds on osteoporosis.

Wang X, Qu Z, Zhao S, Luo L, Yan L Mol Med. 2024; 30(1):193.

PMID: 39468464 PMC: 11520425. DOI: 10.1186/s10020-024-00957-x.


The scaffold protein AXIN1: gene ontology, signal network, and physiological function.

Qiu L, Sun Y, Ning H, Chen G, Zhao W, Gao Y Cell Commun Signal. 2024; 22(1):77.

PMID: 38291457 PMC: 10826278. DOI: 10.1186/s12964-024-01482-4.


Genetic Factors of Teeth Impaction: Polymorphic and Haplotype Variants of , , , and Genes.

Trybek G, Jaron A, Gabrysz-Trybek E, Rutkowska M, Markowska A, Chmielowiec K Int J Mol Sci. 2023; 24(18).

PMID: 37762190 PMC: 10530430. DOI: 10.3390/ijms241813889.


Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk.

Qin K, Yu M, Fan J, Wang H, Zhao P, Zhao G Genes Dis. 2023; 11(1):103-134.

PMID: 37588235 PMC: 10425814. DOI: 10.1016/j.gendis.2023.01.030.